Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard M Scearce

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Cell Reports|January 4, 2016
Structural Constraints of Vaccine-Induced Tier-2 Autologous HIV Neutralizing Antibodies Targeting the Receptor-Binding SiteTodd Bradley, Daniela Fera, Jinal Bhiman, et al.
Nature Communications|February 21, 2020
Immune checkpoint modulation enhances HIV-1 antibody inductionTodd Bradley, Masayuki Kuraoka, Chen-Hao Yeh, et al.
Ebiomedicine|September 11, 2016
Amino Acid Changes in the HIV-1 gp41 Membrane Proximal Region Control Virus Neutralization SensitivityTodd Bradley, Ashley Trama, Nancy Tumba, et al.
The Journal of Experimental Medicine|April 7, 2010
Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce beta-chemokinesM Anthony Moody, Hua-Xin Liao, S Munir Alam, et al.
Immunity|December 20, 2014
Antibody light-chain-restricted recognition of the site of immune pressure in the RV144 HIV-1 vaccine trial is phylogenetically conservedKevin Wiehe, David Easterhoff, Kan Luo, et al.
Cell Reports|March 2, 2017
Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman PrimatesKevin O Saunders, Nathan I Nicely, Kevin Wiehe, et al.
Nature|February 3, 2017
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccinationNorbert Pardi, Michael J Hogan, Rebecca S Pelc, et al.
The Journal of Experimental Medicine|May 10, 2018
Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responsesNorbert Pardi, Michael J Hogan, Martin S Naradikian, et al.
Nature|April 5, 2013
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virusHua-Xin Liao, Rebecca Lynch, Tongqing Zhou, et al.
JCI Insight|December 13, 2016
Tissue memory B cell repertoire analysis after ALVAC/AIDSVAX B/E gp120 immunization of rhesus macaquesKan Luo, Hua-Xin Liao, Ruijun Zhang, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Cell Reports|January 4, 2016
Structural Constraints of Vaccine-Induced Tier-2 Autologous HIV Neutralizing Antibodies Targeting the Receptor-Binding SiteTodd Bradley, Daniela Fera, Jinal Bhiman, et al.
Nature Communications|February 21, 2020
Immune checkpoint modulation enhances HIV-1 antibody inductionTodd Bradley, Masayuki Kuraoka, Chen-Hao Yeh, et al.
Ebiomedicine|September 11, 2016
Amino Acid Changes in the HIV-1 gp41 Membrane Proximal Region Control Virus Neutralization SensitivityTodd Bradley, Ashley Trama, Nancy Tumba, et al.
The Journal of Experimental Medicine|April 7, 2010
Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce beta-chemokinesM Anthony Moody, Hua-Xin Liao, S Munir Alam, et al.
Immunity|December 20, 2014
Antibody light-chain-restricted recognition of the site of immune pressure in the RV144 HIV-1 vaccine trial is phylogenetically conservedKevin Wiehe, David Easterhoff, Kan Luo, et al.
Cell Reports|March 2, 2017
Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman PrimatesKevin O Saunders, Nathan I Nicely, Kevin Wiehe, et al.
Nature|February 3, 2017
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccinationNorbert Pardi, Michael J Hogan, Rebecca S Pelc, et al.
The Journal of Experimental Medicine|May 10, 2018
Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responsesNorbert Pardi, Michael J Hogan, Martin S Naradikian, et al.
Nature|April 5, 2013
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virusHua-Xin Liao, Rebecca Lynch, Tongqing Zhou, et al.
JCI Insight|December 13, 2016
Tissue memory B cell repertoire analysis after ALVAC/AIDSVAX B/E gp120 immunization of rhesus macaquesKan Luo, Hua-Xin Liao, Ruijun Zhang, et al.
Pageof 4